Charles Sternberg, Associate Editor11.16.23
HealthpointCapital, a private equity firm in musculoskeletal healthcare, has welcomed Gary Stevenson to the Firm's leadership team as Managing Director.
As co-founder and managing partner of MB Venture Partners (MBVP), a Memphis, TN-based venture capital firm, Stevenson brings to HealthpointCapital over 20 years of life sciences investing experience. With MBVP, Stevenson invested and was deeply involved with fast-growing musculoskeletal companies such as BioMimetic Therapeutics, Cayenne Medical, CrossRoads Extremity Systems, and Salient Surgical Technologies, all successfully sold to the leading strategic acquirers in the sector.
For 21 consecutive years, Stevenson has organized and hosted one of the premier investment and networking events in the sector, the Musculoskeletal New Ventures Conference, bringing together over 35 emerging companies and broad range of entrepreneurs, investors, consultants and business development professionals from the industry.
Earlier in his career, Stevenson worked in healthcare investment banking and equity research, and at Abbott Labs. He holds an accounting degree from the University of Missouri, an MBA from Kellogg School of Management at Northwestern University, and is a certified public accountant and chartered financial analyst.
Commenting on the announcement, John H. Foster, Managing Partner, said: "I am thrilled to welcome Gary to the team. He is a recognized leader in the medical technology investing community and a tremendous investor with a proven track record of identifying and executing on exciting opportunities in our sector."
Mike Mogul, Managing Partner, commented: "Gary's addition further develops our talented team with significant investment and operational experience and strong relationships across the healthcare industry. As an early investor and fellow Director on the Board of Crossroads Extremity Systems, we have already worked together successfully and I look forward to his joining HealthpointCapital."
As co-founder and managing partner of MB Venture Partners (MBVP), a Memphis, TN-based venture capital firm, Stevenson brings to HealthpointCapital over 20 years of life sciences investing experience. With MBVP, Stevenson invested and was deeply involved with fast-growing musculoskeletal companies such as BioMimetic Therapeutics, Cayenne Medical, CrossRoads Extremity Systems, and Salient Surgical Technologies, all successfully sold to the leading strategic acquirers in the sector.
For 21 consecutive years, Stevenson has organized and hosted one of the premier investment and networking events in the sector, the Musculoskeletal New Ventures Conference, bringing together over 35 emerging companies and broad range of entrepreneurs, investors, consultants and business development professionals from the industry.
Earlier in his career, Stevenson worked in healthcare investment banking and equity research, and at Abbott Labs. He holds an accounting degree from the University of Missouri, an MBA from Kellogg School of Management at Northwestern University, and is a certified public accountant and chartered financial analyst.
Commenting on the announcement, John H. Foster, Managing Partner, said: "I am thrilled to welcome Gary to the team. He is a recognized leader in the medical technology investing community and a tremendous investor with a proven track record of identifying and executing on exciting opportunities in our sector."
Mike Mogul, Managing Partner, commented: "Gary's addition further develops our talented team with significant investment and operational experience and strong relationships across the healthcare industry. As an early investor and fellow Director on the Board of Crossroads Extremity Systems, we have already worked together successfully and I look forward to his joining HealthpointCapital."
